CDCTF Financial Statements & Analysis
Complete financial statements for CDCTF including income statement, balance sheet, and cash flow statement. Analyze CDCTF's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
4.6% ↑
Net Income
17.6% ↑
Gross Margin
-0.1% ↓
Operating Margin
14.0% ↑
Balance Sheet
Current Ratio
5827.8% ↑
Debt to Equity
117.8% ↓
Asset Turnover
-28.4% ↓
Cash Flow
Operating Cash Flow
40.2% ↑
Net Cash Flow
-4151.7% ↓
Free Cash Flow
-1133.8% ↓
Cash Flow to Debt
73.2% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2025 | 2026 | Change | Impact |
|---|---|---|---|---|
| Revenue | 29.29B | 30.64B | 4.6% | |
| Gross Profit | 14.32B | 14.97B | 4.5% | |
| Operating Income | 7.52B | 8.97B | 19.3% | |
| Net Income | 5.01B | 5.90B | 17.6% | |
| EPS | 150.88 | 177.36 | 17.6% | |
| EBITDA | 8.61B | 10.57B | 22.8% | |
| Gross Margin | 48.90% | 48.85% | 0.1% | |
| Operating Margin | 25.66% | 29.27% | 14.0% | |
| Net Income Margin | 17.12% | 19.25% | 12.5% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 30.64B | 29.29B | 24.84B | — | — |
| Gross Profit | 14.97B | 14.32B | 11.81B | — | — |
| Operating Income | 8.97B | 7.52B | 5.74B | — | — |
| Net Income | 5.90B | 5.01B | 3.75B | — | — |
| EPS | 177.36 | 150.88 | 112.90 | — | — |
| EBITDA | 10.57B | 8.61B | 6.86B | — | — |
| Gross Margin | 48.85% | 48.90% | 47.54% | — | — |
| Operating Margin | 29.27% | 25.66% | 23.08% | — | — |
| Net Income Margin | 19.25% | 17.12% | 15.11% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into CDCTF's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics